News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
833,458 Results
Type
Article (75606)
Company Profile (719)
Press Release (757112)
Multimedia
Podcasts (171)
Webinars (28)
Section
Business (228160)
Career Advice (3736)
Deals (39433)
Drug Delivery (139)
Drug Development (89754)
Employer Resources (203)
FDA (18066)
Job Trends (17222)
News (389286)
Policy (39026)
Tag
Academia (3004)
Academic (1)
Accelerated approval (18)
Adcomms (35)
Allergies (128)
Alliances (56203)
ALS (147)
Alzheimer's disease (1688)
Antibody-drug conjugate (ADC) (260)
Approvals (18099)
Artificial intelligence (472)
Autoimmune disease (97)
Automation (29)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (444)
Bladder cancer (138)
Brain cancer (53)
Breast cancer (517)
Cancer (4080)
Cardiovascular disease (355)
Career advice (3200)
Career pathing (38)
CAR-T (251)
CDC (57)
Cell therapy (683)
Cervical cancer (33)
Clinical research (74593)
Collaboration (1433)
Company closure (4)
Compensation (944)
Complete response letters (61)
COVID-19 (2961)
CRISPR (84)
C-suite (611)
Cystic fibrosis (140)
Data (4760)
Decentralized trials (2)
Denatured (61)
Depression (111)
Diabetes (458)
Diagnostics (7093)
Digital health (35)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (213)
Drug pricing (193)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (96369)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (132169)
Executive appointments (996)
FDA (20614)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1281)
Gene editing (177)
Generative AI (42)
Gene therapy (554)
GLP-1 (1029)
Government (5346)
Grass and pollen (8)
Guidances (369)
Healthcare (20918)
HIV (47)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (250)
Immuno-oncology (22)
Indications (58)
Infectious disease (3209)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (101)
Intellectual property (196)
Interviews (730)
IPO (17863)
IRA (59)
Job creations (5013)
Job search strategy (2601)
Kidney cancer (16)
Labor market (81)
Layoffs (640)
Leadership (37)
Legal (9962)
Liver cancer (92)
Longevity (12)
Lung cancer (586)
Lymphoma (269)
Machine learning (31)
Management (66)
Manufacturing (654)
MASH (145)
Medical device (14877)
Medtech (14902)
Mergers & acquisitions (22469)
Metabolic disorders (1174)
Multiple sclerosis (140)
NASH (23)
Neurodegenerative disease (232)
Neuropsychiatric disorders (63)
Neuroscience (2742)
NextGen: Class of 2025 (7644)
Non-profit (5094)
Now hiring (60)
Obesity (568)
Opinion (315)
Ovarian cancer (139)
Pain (170)
Pancreatic cancer (176)
Parkinson's disease (242)
Partnered (29)
Patents (427)
Patient recruitment (331)
Peanut (57)
People (65175)
Pharmaceutical (138)
Pharmacy benefit managers (28)
Phase I (23052)
Phase II (32512)
Phase III (24525)
Pipeline (2801)
Policy (300)
Postmarket research (3264)
Preclinical (10180)
Press Release (72)
Prostate cancer (203)
Psychedelics (52)
Radiopharmaceuticals (281)
Rare diseases (695)
Real estate (7195)
Recruiting (79)
Regulatory (27429)
Reports (65)
Research institute (2689)
Resumes & cover letters (581)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (213)
Series B (159)
Service/supplier (27)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (169)
Sponsored (41)
Startups (4228)
State (2)
Stomach cancer (17)
Supply chain (101)
Tariffs (96)
The Weekly (108)
Vaccines (1056)
Venture capital (67)
Weight loss (401)
Women's health (58)
Worklife (21)
Date
Today (154)
Last 7 days (749)
Last 30 days (2895)
Last 365 days (32834)
2025 (27098)
2024 (37910)
2023 (42567)
2022 (53927)
2021 (58723)
2020 (57663)
2019 (51306)
2018 (39087)
2017 (36853)
2016 (37777)
2015 (43761)
2014 (38468)
2013 (34452)
2012 (36348)
2011 (36468)
2010 (35931)
Location
Africa (1206)
Alabama (80)
Alaska (7)
Arizona (287)
Arkansas (14)
Asia (49688)
Australia (8512)
California (9700)
Canada (2904)
China (934)
Colorado (410)
Connecticut (429)
Delaware (277)
Europe (112362)
Florida (1429)
Georgia (320)
Hawaii (3)
Idaho (66)
Illinois (804)
India (54)
Indiana (479)
Iowa (20)
Japan (332)
Kansas (125)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1299)
Massachusetts (7248)
Michigan (314)
Minnesota (575)
Mississippi (4)
Missouri (123)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2696)
New Mexico (32)
New York (2628)
North Carolina (1418)
North Dakota (10)
Northern California (4437)
Ohio (304)
Oklahoma (22)
Oregon (49)
Pennsylvania (2011)
Puerto Rico (20)
Rhode Island (46)
South America (1571)
South Carolina (50)
South Dakota (1)
Southern California (3705)
Tennessee (151)
Texas (1514)
United States (35650)
Utah (291)
Virginia (249)
Washington D.C. (84)
Washington State (829)
West Virginia (4)
Wisconsin (97)
Wyoming (1)
833,458 Results for "sumitomo dainippon pharma co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
Press Releases
Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis
July 30, 2025
·
4 min read
Press Releases
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
October 31, 2025
·
8 min read
Press Releases
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome
October 30, 2025
·
13 min read
Press Releases
Nielsen BioSciences Announces Expanded CANDIN License Agreement with Maruho Co. Ltd.
October 24, 2025
·
3 min read
Press Releases
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
October 30, 2025
·
13 min read
Press Releases
Sumitomo Pharma America Announces that Nuvisertib (TP-3654) Has Received FDA Fast Track Designation for the Treatment of Myelofibrosis
June 13, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
October 14, 2025
·
10 min read
Press Releases
Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
October 1, 2025
·
6 min read
Press Releases
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it’s Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
June 30, 2025
·
8 min read
1 of 83,346
Next
